The approved therapy Attruby (acoramidis) significantly lowered the risk of a first heart failure event in people with transthyretin amyloid cardiomyopathy (ATTR-CM), according…
News
Hereditary transthyretin amyloidosis (hATTR), a group of conditions including hATTR with polyneuropathy (hATTR-PN) and hereditary ATTR cardiomyopathy (hATTR-CM), does not cause damage to…
For people with transthyretin amyloid cardiomyopathy (ATTR-CM), starting treatment earlier with the approved med Amvuttra (vutrisiran) can reduce the risk of serious heart…
Patient enrollment has been completed in a late-stage clinical trial testing nexiguran ziclumeran (nex-z), Intellia Therapeutics’ experimental one-time gene-editing therapy, in people with…
An artificial intelligence (AI)-derived algorithm analyzing data from a standard, noninvasive heart test may help doctors identify transthyretin amyloid cardiomyopathy (ATTR-CM) among people with…
HATTR-PN
NewsHeart scans detect early changes in hATTR-PN carriers
People carrying mutations known to cause hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN) who are not yet showing symptoms may already have disease-associated toxic protein…
Vyndamax (tafamidis) leads to rapid and sustained increases in blood levels of the transthyretin (TTR) protein in people with transthyretin amyloid cardiomyopathy (ATTR-CM),…
An international team of experts has published new guidelines for diagnosing and treating hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN) and forms of the disease…
Oct. 26 is World Amyloidosis Day, and advocates around the world are joining together to shine a light on transthyretin amyloid cardiomyopathy (ATTR-CM) and…
Most people with transthyretin amyloidosis (ATTR) in China have a hereditary form of the rare disease and experience symptoms of both ATTR with polyneuropathy…
Recent Posts
- Therapy cuts risk of first heart failure event by 45% in ATTR-CM trial
- Brain MRI reveals no small blood vessel damage in hATTR, study finds
- Starting approved ATTR-CM drug earlier may cut risk of heart problems
- Dealing with caregiver guilt is a burden we rarely discuss
- Seattle VA teams with support group for faster ATTR-CM diagnosis in veterans